Conditions: Type 2 Diabetes Mellitus
Keywords: MT-2412 MP-513 TA-7284 Teneligliptin Canagliflozin
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 153
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the safety and efficacy of co-administration of Teneligliptin (MP-513) and Canagliflozin (TA-7284) once daily for 52 weeks in Japanese patients with Type 2 diabetes mellitus who are receiving treatment with Teneligliptin and have inadequate glycemic control.

Detailed description:

Arms:
arm 1: Patients receive Teneligliptin and Canagliflozin once daily for 52 weeks.

Interventions: intervention 1: Teneligliptin/Canagliflozin
Intervention descriptions: intervention 1: Co-administration of Teneligliptin and Canagliflozin orally once daily for 52 weeks.

Protocol document: